USAID Announces New Award to Prevent and Repair Obstetric Fistula

For Immediate Release

Monday, January 6, 2014
USAID Press Office
202-712-4320 | Email:

WASHINGTON, D.C. – Taking one more step toward improving maternal health globally, the U.S. Agency for International Development (USAID) announces the award of the Fistula Care Plus Project to EngenderHealth and its institutional partner, the Population Council. Obstetric fistula, a hole that develops between the birth canal and one or more of a woman's internal organs, is caused by obstructed labor without access to timely and skilled medical care, such as cesarean section. Delaying the age of first pregnancy and increasing access to contraception are also critical to the prevention of fistula. Fistula results in chronic, uncontrollable leakage of urine and/or feces, a devastating lifelong disability that affects a significant number of girls and women in Africa and Asia. New cases, all preventable, are continuing to occur. Often women who have fistula from obstructed labor also bear the sorrow of the loss of the baby.

Fistula Care Plus is a five-year cooperative agreement with a ceiling of $74.49M. The overall objective of the project is to strengthen health system capacity for fistula prevention, detection, treatment and reintegration in Sub-Saharan Africa and South Asia. Activities will begin immediately in Bangladesh, Democratic Republic of Congo, Sierra Leone, Niger, Nigeria, and Uganda. The project will strengthen environments to enable for fistula prevention and treatment, increase community awareness and support for women and girls with fistula, reduce barriers to accessing prevention, detection, and care, and improve the evidence base for approaches to improve fistula care. The activities will focus on new partnerships, innovations and sustainable approaches.

“Women with fistula live a devastated and painful existence that not only impacts their marriages and makes them social outcasts, but threatens their health and the health of their children,” said Dr. Ariel Pablos-Mendez, Assistant Administrator for the Bureau for Global Health at USAID. “Together with our partners, USAID will continue to transform the lives of women living with fistula and work to address the underlying causes.”

Since 2004, USAID has supported programs to prevent and treat fistula, including clinical services, work with communities to find cases and reduce stigma, and research to improve understanding of risk factors and treatment approaches. In that time, USAID has supported programs in 15 countries at 57 health facilities across Africa and Asia. USAID has funded more than 33,000 fistula repair surgeries and trained thousands of individuals, including surgeons, nurses, and health care and community outreach workers, on fistula repair surgery and care, thereby creating a sustained network of individual and fistula repair centers that can provide treatment for the enormous backlog of women living with fistula and awaiting surgery. Equally important, USAID promotes a robust program of fistula prevention through family planning, early identification of prolonged labor and prompt treatment with Caesarean section, and safe surgical practices to prevent fistula caused by surgical injury.

Other partners who will be working with EngenderHealth include Dimagi, TERREWODE, Direct Relief, the Fistula Foundation, and the Maternal Health Task Force, all of whom will be coordinating to make fistula as rare in Africa and Asia as it is in the Americas and Europe today. Fistula is a problem that can be prevented with family planning and access to timely and skilled maternity care. Fistula Care Plus is one more step to ensuring that no mother or child suffers from something we could have prevented and the prevention strategies for women in labor are an essential component of improving pregnancy outcome and newborn survival. USAID’s work on fistula prevention is part of USAID’s goal of ending preventable child and maternal deaths.

For more information about the U.S. Agency for International Development, visit our website at